Home

RxSight, Inc. - Common Stock (RXST)

8.8900
+0.4200 (4.96%)
NASDAQ · Last Trade: Sep 6th, 5:35 AM EDT
QuoteNewsPress ReleasesChartHistoricalFAQAboutCompetitors

Detailed Quote

Previous Close8.470
Open8.550
Bid8.900
Ask9.280
Day's Range8.520 - 9.190
52 Week Range6.320 - 57.53
Volume1,351,722
Market Cap302.10M
PE Ratio (TTM)-11.11
EPS (TTM)-0.8
Dividend & YieldN/A (N/A)
1 Month Average Volume1,273,929

Chart

About RxSight, Inc. - Common Stock (RXST)

Rxsight Inc is a healthcare technology company that focuses on enhancing vision correction through its innovative approach to personalized refractive surgery. The company develops advanced systems that utilize sophisticated algorithms and proprietary software to optimize intraocular lenses for patients undergoing cataract surgery. By combining data-driven insights with precision eye care, Rxsight aims to improve visual outcomes for patients, ultimately advancing the standards of treatment in the ophthalmic field. Their commitment to personalized medicine is reflected in their ongoing research and development efforts to create more effective solutions for vision-related challenges. Read More

News & Press Releases

Class Action Filed Against RxSight, Inc. (RXST) Seeking Recovery for Investors - Contact Levi & Korsinsky
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
Via NewMediaWire · September 5, 2025
Class Action Filed Against RxSight, Inc. (RXST) Seeking Recovery for Investors - Contact Levi & Korsinsky
NEW YORK - September 5, 2025 ( NEWMEDIAWIRE ) - Levi & Korsinsky, LLP notifies investors in RxSight, Inc. (NASDAQ: RXST) of a class action securities lawsuit.
Via TheNewswire.com · September 5, 2025
RxSight, Inc. Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights - RXST
The DJS Law Group reminds investors of a class action lawsuit against RxSight, Inc. (“RxSight” or “the Company”) (NASDAQ: RXST) violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission.
By DJS Law Group · Via Business Wire · September 4, 2025
Levi & Korsinsky Reminds Shareholders of a Lead Plaintiff Deadline of September 22, 2025 in RxSight, Inc. Lawsuit - RXST
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
Via NewMediaWire · September 4, 2025
Levi & Korsinsky Reminds Shareholders of a Lead Plaintiff Deadline of September 22, 2025 in RxSight, Inc. Lawsuit - RXST
NEW YORK - September 4, 2025 ( NEWMEDIAWIRE ) - Levi & Korsinsky, LLP notifies investors in RxSight, Inc. (NASDAQ: RXST) of a class action securities lawsuit.
Via TheNewswire.com · September 4, 2025
DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of RxSight
Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In RxSight To Contact Him Directly To Discuss Their Options
By Faruqi & Faruqi LLP · Via GlobeNewswire · September 3, 2025
RXST DEADLINE: ROSEN, NATIONAL INVESTOR COUNSEL, Encourages RxSight, Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important Deadline in Securities Class Action – RXST
NEW YORK, Sept. 03, 2025 (GLOBE NEWSWIRE) --
By The Rosen Law Firm PA · Via GlobeNewswire · September 3, 2025
Levi & Korsinsky Notifies Shareholders of RxSight, Inc. (RXST) of a Class Action Lawsuit and an Upcoming Deadline
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
Via NewMediaWire · September 3, 2025
Levi & Korsinsky Notifies Shareholders of RxSight, Inc. (RXST) of a Class Action Lawsuit and an Upcoming Deadline
NEW YORK - September 3, 2025 ( NEWMEDIAWIRE ) - Levi & Korsinsky, LLP notifies investors in RxSight, Inc. (NASDAQ: RXST) of a class action securities lawsuit.
Via TheNewswire.com · September 3, 2025
RXSIGHT ALERT: Bragar Eagel & Squire, P.C. Announces that a Class Action Lawsuit Has Been Filed Against RxSight, Inc. and Encourages Investors to Contact the Firm
Bragar Eagel & Squire, P.C. Litigation Partner Brandon Walker Encourages Investors Who Suffered Losses In RxSight (RXST) To Contact Him Directly To Discuss Their Options
By Bragar Eagel & Squire · Via GlobeNewswire · September 3, 2025
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in RxSight, Inc. of Class Action Lawsuit and Upcoming Deadlines - RXST
NEW YORK, Sept. 02, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP announces that a class action lawsuit has been filed against RxSight, Inc. (“RxSight” or the “Company”)(NASDAQ: RXST). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext. 7980. Those who inquire by e-mail are encouraged to include their mailing address, telephone number, and the number of shares purchased.
By Pomerantz LLP · Via GlobeNewswire · September 2, 2025
RXSIGHT, INC. (NASDAQ: RXST) SHAREHOLDER ALERT Bernstein Liebhard LLP Reminds RxSight Inc. Investors of Upcoming Deadline
NEW YORK, Sept. 02, 2025 (GLOBE NEWSWIRE) -- Bernstein Liebhard LLP, a nationally acclaimed investor rights law firm, reminds RxSight, Inc. (“RxSight” or the “Company”) (NASDAQ: RXST) investors of an upcoming deadline involving a securities fraud class action lawsuit commenced against the Company.
By Bernstein Liebhard LLP · Via GlobeNewswire · September 2, 2025
Class Action Filed Against RxSight, Inc. (RXST) - September 22, 2025 Deadline to Join - Contact Levi & Korsinsky
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
Via NewMediaWire · September 2, 2025
Class Action Filed Against RxSight, Inc. (RXST) - September 22, 2025 Deadline to Join - Contact Levi & Korsinsky
NEW YORK - September 2, 2025 ( NEWMEDIAWIRE ) - Levi & Korsinsky, LLP notifies investors in RxSight, Inc. (NASDAQ: RXST) of a class action securities lawsuit.
Via TheNewswire.com · September 2, 2025
Bragar Eagel & Squire, P.C. Reminds Investors of Class Actions Against Neogen, Alto, RxSight, and Replimune and Encourages Investors to Contact the Firm
NEW YORK, Aug. 30, 2025 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, reminds investors that class actions have been commenced on behalf of stockholders of Neogen Corporation (NASDAQ:NEOG), Alto Neuroscience, Inc. (NYSE:ANRO), RxSight, Inc. (NASDAQ:RXST), and Replimune Group, Inc. (NASDAQ:REPL). Stockholders have until the deadlines below to petition the court to serve as lead plaintiff. Additional information about each case can be found at the link provided.
By Bragar Eagel & Squire · Via GlobeNewswire · August 30, 2025
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in RxSight, Inc. of Class Action Lawsuit and Upcoming Deadlines - RXST
NEW YORK, Aug. 29, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP announces that a class action lawsuit has been filed against RxSight, Inc. (“RxSight” or the “Company”) (NASDAQ: RXST). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext. 7980. Those who inquire by e-mail are encouraged to include their mailing address, telephone number, and the number of shares purchased.
By Pomerantz LLP · Via GlobeNewswire · August 29, 2025
ROSEN, GLOBAL INVESTOR COUNSEL, Encourages RxSight, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – RXST
NEW YORK, Aug. 28, 2025 (GLOBE NEWSWIRE) --
By The Rosen Law Firm PA · Via GlobeNewswire · August 28, 2025
SHAREHOLDER NOTICE: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of RxSight
Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $75,000 In RxSight To Contact Him Directly To Discuss Their Options
By Faruqi & Faruqi LLP · Via GlobeNewswire · August 28, 2025
Levi & Korsinsky Notifies RxSight, Inc. Investors of a Class Action Lawsuit and Upcoming Deadline - RXST
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
Via NewMediaWire · August 28, 2025
Levi & Korsinsky Notifies RxSight, Inc. Investors of a Class Action Lawsuit and Upcoming Deadline - RXST
NEW YORK - August 28, 2025 ( NEWMEDIAWIRE ) - Levi & Korsinsky, LLP notifies investors in RxSight, Inc. (NASDAQ: RXST) of a class action securities lawsuit.
Via TheNewswire.com · August 28, 2025
Levi & Korsinsky Reminds Shareholders of a Lead Plaintiff Deadline of September 22, 2025 in RxSight, Inc. Lawsuit - RXST
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
Via NewMediaWire · August 27, 2025
Levi & Korsinsky Reminds Shareholders of a Lead Plaintiff Deadline of September 22, 2025 in RxSight, Inc. Lawsuit - RXST
NEW YORK - August 27, 2025 ( NEWMEDIAWIRE ) - Levi & Korsinsky, LLP notifies investors in RxSight, Inc. (NASDAQ: RXST) of a class action securities lawsuit.
Via TheNewswire.com · August 27, 2025
Class Action Filed Against RxSight, Inc. (RXST) - September 22, 2025 Deadline to Join - Contact Levi & Korsinsky
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
Via NewMediaWire · August 26, 2025
Class Action Filed Against RxSight, Inc. (RXST) - September 22, 2025 Deadline to Join - Contact Levi & Korsinsky
NEW YORK - August 26, 2025 ( NEWMEDIAWIRE ) - Levi & Korsinsky, LLP notifies investors in RxSight, Inc. (NASDAQ: RXST) of a class action securities lawsuit.
Via TheNewswire.com · August 26, 2025
Bragar Eagel & Squire, P.C. Reminds Investors of Class Actions Against Neogen, Alto, RxSight, and Replimune and Encourages Investors to Contact the Firm
NEW YORK, Aug. 26, 2025 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, reminds investors that class actions have been commenced on behalf of stockholders of Neogen Corporation (NASDAQ:NEOG), Alto Neuroscience, Inc. (NYSE:ANRO), RxSight, Inc. (NASDAQ:RXST), and Replimune Group, Inc. (NASDAQ:REPL). Stockholders have until the deadlines below to petition the court to serve as lead plaintiff. Additional information about each case can be found at the link provided.
By Bragar Eagel & Squire · Via GlobeNewswire · August 26, 2025